Analysts See $0.35 EPS for VeriFone Systems (PAY); Leap Therapeutics (LPTX) Shorts Increased By 94.03%

November 15, 2017 - By Hazel Jackson

Leap Therapeutics Incorporated (NASDAQ:LPTX) had an increase of 94.03% in short interest. LPTX’s SI was 39,000 shares in November as released by FINRA. Its up 94.03% from 20,100 shares previously. With 23,100 avg volume, 2 days are for Leap Therapeutics Incorporated (NASDAQ:LPTX)’s short sellers to cover LPTX’s short positions. The SI to Leap Therapeutics Incorporated’s float is 1%. About 3,000 shares traded. Leap Therapeutics Inc (NASDAQ:LPTX) has 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts expect VeriFone Systems Inc (NYSE:PAY) to report $0.35 EPS on December, 12 after the close.They anticipate $0.14 EPS change or 66.67% from last quarter’s $0.21 EPS. PAY’s profit would be $39.17 million giving it 12.64 P/E if the $0.35 EPS is correct. After having $0.28 EPS previously, VeriFone Systems Inc’s analysts see 25.00% EPS growth. The stock decreased 0.84% or $0.15 during the last trading session, reaching $17.69. About shares traded. VeriFone Systems Inc (NYSE:PAY) has declined 31.93% since November 15, 2016 and is downtrending. It has underperformed by 48.63% the S&P500.

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The company has market cap of $56.21 million. The Firm engages in acquiring and developing therapeutics in cancer biology. It currently has negative earnings. The Company’s lead product candidates for use in clinical trials include TRX518 and DKN-01.

Investors sentiment increased to 1.16 in Q2 2017. Its up 0.11, from 1.05 in 2017Q1. It increased, as 30 investors sold VeriFone Systems Inc shares while 71 reduced holdings. 32 funds opened positions while 85 raised stakes. 117.62 million shares or 2.67% more from 114.56 million shares in 2017Q1 were reported. Royal Retail Bank Of Canada owns 143,358 shares or 0% of their US portfolio. Commonwealth Of Pennsylvania Pub School Empls Retrmt System reported 0% in VeriFone Systems Inc (NYSE:PAY). First Quadrant Lp Ca stated it has 0% in VeriFone Systems Inc (NYSE:PAY). Hanson & Doremus Mgmt holds 0.72% of its portfolio in VeriFone Systems Inc (NYSE:PAY) for 107,215 shares. Menta Capital Limited Liability holds 0.13% or 58,570 shares. Guinness Asset Mgmt Ltd owns 178,150 shares. Macquarie Gru Limited has 0.02% invested in VeriFone Systems Inc (NYSE:PAY). Morgan Stanley has invested 0% in VeriFone Systems Inc (NYSE:PAY). 124,100 are held by Putnam Investments Ltd Limited Liability Company. 10,831 are owned by Shelton Mgmt. American Century owns 1.22M shares. Moreover, Emerald Advisers Inc Pa has 0.04% invested in VeriFone Systems Inc (NYSE:PAY). Ancora Advisors Ltd Llc accumulated 13,850 shares. Barclays Public Limited Com stated it has 0.01% in VeriFone Systems Inc (NYSE:PAY). Cambiar Ltd reported 0.4% in VeriFone Systems Inc (NYSE:PAY).

Among 31 analysts covering Verifone Systems Inc. (NYSE:PAY), 10 have Buy rating, 1 Sell and 20 Hold. Therefore 32% are positive. Verifone Systems Inc. had 71 analyst reports since August 5, 2015 according to SRatingsIntel. The company was maintained on Friday, June 9 by BTIG Research. Barclays Capital downgraded the shares of PAY in report on Wednesday, June 8 to “Equal-Weight” rating. The stock of VeriFone Systems Inc (NYSE:PAY) has “Neutral” rating given on Tuesday, December 15 by Goldman Sachs. The firm has “Neutral” rating by Northcoast given on Wednesday, September 6. The firm earned “Buy” rating on Monday, October 17 by Craig Hallum. The stock of VeriFone Systems Inc (NYSE:PAY) has “Hold” rating given on Friday, October 13 by RBC Capital Markets. The rating was initiated by Citigroup with “Hold” on Friday, September 15. The firm earned “Equal-Weight” rating on Friday, September 2 by Barclays Capital. The company was maintained on Saturday, September 5 by Pacific Crest. The company was initiated on Friday, January 6 by BMO Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com